Literature DB >> 12486427

Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease.

Shinji Koba1, Tsutomu Hirano, Takeshi Kondo, Masayuki Shibata, Hiroshi Suzuki, Mikitaka Murakami, Eiichi Geshi, Takashi Katagiri.   

Abstract

BACKGROUND: It remains unclear how closely the small dense low-density lipoprotein (LDL) (diameter < or =25.5 nm) is associated with various types of coronary heart disease (CHD) in Japanese patients, an ethnic group with lower serum cholesterol levels and less massive obesity compared with Western populations. METHODS AND
RESULTS: We measured mean LDL particle diameter by gradient gel electrophoresis in 571 patients with CHD and in 263 healthy subjects who served as control patients. Patients with CHD were classified into acute coronary syndrome (ACS), stable CHD and vasospastic angina. High-density lipoprotein cholesterol and apolipoprotein-A1 and -B were significantly different between patients with CHD and controls. LDL size in patients with CHD was markedly smaller than that in controls in both men and women (25.5 +/- 0.7 vs 25.9 +/- 0.4 and 25.7 +/- 0.7 vs 26.0 +/- 0.5 nm, respectively). LDL cholesterol was significantly higher in patients with ACS than in other groups. Plasma levels of high-density lipoprotein cholesterol decreased as the number of diseased vessels or angiographic coronary severity evaluated by Gensini score increased, but the LDL size was comparable irrespective of the type of CHD and the extent and severity of the lesions. Multiple logistic regression analysis revealed that small dense LDL was independently associated with the incidence of CHD in both sexes (odds ratio [OR] 3.5, 95% CI 2.1-5.7, and OR 2.9, 95% CI 1.5-5.6, P <.005).
CONCLUSION: Our study suggests that the small dense LDL is strongly associated with various types of CHD, independent of traditional and nontraditional coronary risk factors, but is not related to the severity and extent of the coronary lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12486427     DOI: 10.1067/mhj.2002.126119

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  16 in total

Review 1.  Low-density lipoprotein particle number and risk for cardiovascular disease.

Authors:  William C Cromwell; James D Otvos
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

2.  Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?

Authors:  Aleksandra Zeljkovic; Vesna Spasojevic-Kalimanovska; Jelena Vekic; Zorana Jelic-Ivanovic; Aleksandra Topic; Natasa Bogavac-Stanojevic; Slavica Spasic; Ana Vujovic; Dimitra Kalimanovska-Ostric
Journal:  Clin Exp Med       Date:  2008-07-11       Impact factor: 3.984

3.  The potential of Cystatin C and small dense LDL as biomarkers of coronary artery disease risk in a young Indian population.

Authors:  Anjali Manocha; Flora Gupta; Rajneesh Jain; Seema Bhargava; Mamta Kankra; Sabari Das; L M Srivastava
Journal:  Mol Cell Biochem       Date:  2013-12-20       Impact factor: 3.396

4.  Non-HDL as a Valid Surrogate Marker of Small Dense LDL in a Young Indian Population.

Authors:  Anjali Manocha; Seema Bhargava; Rajneesh Jain; Mamta Kankra; Parul Singla; Parul Chugh
Journal:  Indian J Clin Biochem       Date:  2018-05-08

5.  Serum small dense low-density lipoprotein concentrations are elevated in patients with significant coronary artery stenosis and are related to features of the metabolic syndrome.

Authors:  Shima Yazdandoust; Seyyed Mohammad Reza Parizadeh; Mohsen Moohebati; Parichehreh Yaghmaei; Amir Ali Rahsepar; Shima Tavallaie; Mohammad Soukhtanloo; Roshanak Khojasteh; Roghayeh Paydar; Afsoon Fazlinezhad; Homa Falsoleiman; Mashalla Dehghani; Majid Ghayour-Mobarhan; Gordon A Ferns
Journal:  Lipids       Date:  2012-08-18       Impact factor: 1.880

6.  Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.

Authors:  Sung Woo Kwon; Se-Jung Yoon; Tae Soo Kang; Hyuck Moon Kwon; Jeong-Ho Kim; Jihyuk Rhee; Sung-Ju Lee; Jong-Kwan Park; Jae Yun Lim; Young Won Yoon; Bum Kee Hong
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

7.  Plant sterols, marine-derived omega-3 fatty acids and other functional ingredients: a new frontier for treating hyperlipidemia.

Authors:  Christopher Pf Marinangeli; Peter Jh Jones
Journal:  Nutr Metab (Lond)       Date:  2010-09-28       Impact factor: 4.169

8.  Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population.

Authors:  Christine M Greene; David Waters; Richard M Clark; John H Contois; Maria Luz Fernandez
Journal:  Nutr Metab (Lond)       Date:  2006-01-06       Impact factor: 4.169

9.  Apolipoprotein B Is Related to Metabolic Syndrome Independently of Low Density Lipoprotein Cholesterol in Patients with Type 2 Diabetes.

Authors:  Younghyup Lim; Soyeon Yoo; Sang Ah Lee; Sang Ouk Chin; Dahee Heo; Jae Cheol Moon; Shinhang Moon; Kiyoung Boo; Seong Taeg Kim; Hye Mi Seo; Hyeyoung Jwa; Gwanpyo Koh
Journal:  Endocrinol Metab (Seoul)       Date:  2015-06

Review 10.  Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis.

Authors:  Enrico Ammirati; Francesco Moroni; Giuseppe Danilo Norata; Marco Magnoni; Paolo G Camici
Journal:  Mediators Inflamm       Date:  2015-04-16       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.